Scrip
Eisai launches Zebinix in the UK
09 November 2009
Asher Mullard
Please Login to read the full article.
09 November 2009
Asher Mullard
Eisai Pharmaceuticals has launched its Zebinix (eslicarbazepine acetate) in the UK as an adjunctive treatment for epilepsy in adults with partial-onset seizures, with or without secondary generalisation. The drug – which is already available in Denmark, Germany and Austria – will cost...
Please Login to read the full article.
RELATED CONTENT
SCIENCE
- Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
- Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
